I think most cells are made by mitosis and don't come from stem cells.
Here's a screenshot of the explanation I received when I was invited on the trial -https://i.imgur.com/H329Vgv.jpg
> "By using BMN 270 to provide the functional genes, it is expected that you may not require treatment for Haemophilia A, as often or at all."
I don't really want to upload the whole Participant Information Sheet because it contains some of the doctor's personal details.
The increase in the pipeline of gene therapies just in the past few months has been incredible.
Here are the ones I'm tracking: BioMarin valoctocogene roxaparvovec (BMN-270) Spark SPK-8011 Sangamo (Pfizer) SB-525 Bioverativ BIVV-001 Shire SHP-654 (BAX-888)
Its quite incredible though, there's only a few thousand people in the UK with haemophilia - this trial just cured like 0.5% of them
Thanks again for the info. Best of luck!
> As for the liver, the human body's detoxifier, its cells' lives are quite short - an adult human liver cell has a turnover time of 300 to 500 days.
https://www.timeshighereducation.com/news/life-span-of-human...
So I think it must be targeting the stem cells or this wouldn't last more than a year or two? EDIT: See Chriky's comment.
It is correct if the therapy is targeting all stem cells. I have not understood clearly from the article but it seems the treatement is targeting "living cells". Once all your 'fixed' cells have been renewed you would need another round of treatement.